EPISODE · Sep 24, 2019 · 30 MIN
A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke
Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL Recorded on September 3, 2019 Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for preparative regimens, suicide genes, dual antigen binding, and so much more. Listen in today! Frederick L. Locke, MD Vice-Chair Research Director and Medical Director, Immune Cell Therapy Program Department of Blood and Marrow Transplant and Cellular Immunotherapy Co-Leader Immunology Program Moffitt Cancer Center Tampa, FL This podcast episode is supported by Allogene Therapeutics, Inc.
NOW PLAYING
A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke
No transcript for this episode yet
Similar Episodes
May 4, 2026 ·16m
Apr 27, 2026 ·17m
Apr 13, 2026 ·16m
Apr 6, 2026 ·16m
Mar 30, 2026 ·16m
Mar 23, 2026 ·17m